Pheast Therapeutics is a cancer immunotherapy company focused on developing novel checkpoint therapies to harness the innate immune system in the fight against cancer.
Location: United States, California, Palo Alto
Employees: 11-50
Total raised: $76M
Founded date: 2020
Investors 2
| Date | Name | Website |
| 08.11.2023 | ARCH Ventu... | archventur... |
| - | Startup Le... | startuplea... |
Funding Rounds 1
| Date | Series | Amount | Investors |
| 27.04.2022 | Series A | $76M | - |
Mentions in press and media 6
| Date | Title | Description |
| 27.04.2022 | Pheast Therapeutics Raises $76M in Series A Funding | Pheast Therapeutics, a Palo Alto, CA-based company developing checkpoint therapies to fight cancer, raised $76M in Series A funding. The round was led by Catalio Capital Management and ARCH Venture Partners with participation from Alexandri... |
| 26.04.2022 | Elon Musk is buying Twitter. Here’s what comes next | This is the web version of Term Sheet, a daily newsletter on the biggest deals and dealmakers. Sign up to get it delivered free to your inbox. Goodbye, TWTR ticker. Hello to the reign of the world’s wealthiest man, Elon Musk. While Musk tak... |
| 26.04.2022 | Pheast Therapeutics Raises $76M Series A Round | PALO ALTO, CA, Pheast Therapeutics, a company developing novel checkpoint therapies to fight cancer, has raised $76 million in Series A funding round. >> Click here for more funding data on Pheast Therapeutics >> To export P... |
| 26.04.2022 | Irv Weissman’s lab spins out Pheast Therapeutics to target new ‘don’t eat me’ signal, $76M Series A led by ARCH Venture | - |
| - | 9 top West Coast biotechs that VCs say are poised to take off in the next year | Tayfun Coskun/Anadolu Agency/Getty Images This story is available exclusively to Insider subscribers. Become an Insider and start reading now. Insider asked 12 venture capitalists which biotech startups would take off in the next 12 months.... |
| - | Meet the 23 biotech startups that are set to take off in the next 12 months, according to top VCs | Tyler Le/Insider This story is available exclusively to Insider subscribers. Become an Insider and start reading now. Insider asked 12 venture capitalists which biotech startups would take off in the next 12 months. Here are the 23 companie... |